David P Bonita Insider Trading $LOXO Loxo Oncology, Inc.
Get free email notifications about insider trading for David P Bonita.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David P Bonita. David P Bonita is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Director in SI-BONE, Inc. ($SIBN) and Director in Acutus Medical, Inc. ($AFIB) and Director in Loxo Oncology, Inc. ($LOXO) and Director in ViewRay, Inc. ($VRAY) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in IMARA Inc. ($IMRA) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Ikena Oncology, Inc. ($IKNA).
David P Bonita in Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David P Bonita: Director
Holdings: 941,000 shares
Current Value: $37,357,700
Latest Transaction: Dec 12 2017
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David P Bonita in Loxo Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, AMBI, IKNA, IMRA, LOXO, PRLD, RPTX, SIBN, TCDA, VRAY
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 82.50 | 250,000 | 20,625,000 | 941,000 | 1.2 M to 941 K (-20.99 %) |
| Nov 27 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 75.00 | 267,000 | 20,025,000 | 1,191,000 | 1.5 M to 1.2 M (-18.31 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 76.23 | 8,377 | 638,579 | 1,458,000 | 1.5 M to 1.5 M (-0.57 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 75.37 | 71,598 | 5,396,341 | 1,466,377 | 1.5 M to 1.5 M (-4.66 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 74.49 | 100,045 | 7,452,352 | 1,537,975 | 1.6 M to 1.5 M (-6.11 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 73.48 | 43,300 | 3,181,684 | 1,638,020 | 1.7 M to 1.6 M (-2.58 %) |
| Nov 20 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 72.46 | 46,680 | 3,382,433 | 1,681,320 | 1.7 M to 1.7 M (-2.70 %) |
| Jun 23 2017 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Option Exercise | A | 78.58 | 11,000 | 864,380 | 11,000 | |
| Aug 12 2016 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Sell | S | 26.96 | 447,857 | 12,074,225 | 1,728,000 | 2.2 M to 1.7 M (-20.58 %) |
| Jun 13 2016 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Option Exercise | A | 24.18 | 7,812 | 188,894 | 7,812 | |
| Jul 30 2015 | LOXO | Loxo Oncology, Inc ... | Bonita David P | Director | Option Exercise | A | 20.91 | 7,812 | 163,349 | 7,812 |
Page: 1